Saddened over delay in construction of temple, Lord Rama visits this Waqf Board chief in dream!

Mangaluru, Apr 12: Swift and strict action by the District Administration has resulted in the district achieving ‘Clean’ week with no new cases of COVID-19 reported for the seventh day in a row.

Meanwhile, in a happy coincidence, the district’s only infant allegedly affected – a ten month old child – was totally cured and discharged from the hospital along with infant’s mother and grandmother who were considered to the primary contacts. They are never tested positive for the virus, it is reported. Health experts attributed this to their natural immunity.

The child is said to have contracted the infection during a family visit to Kasargod, which has turned in to a Covid-19 hot spot. The family which hails from Sajipanadu in Bantwal-taluk had been kept in isolation ever since the child had tested positive on March 25. The quarantine was extended to the entire village as a preventive measure and the District Administration undertook the responsibility to providing essential supplies.

Mangaluru, Apr 1: Dakshina Kannada District in-charge minister Kota Srinivas Poojary on Tuesday announced that essential shops including grocery stores, fruits and vegetable shops will be allowed to open from Wednesday between 0700 hrs to 1200 hrs across the district.

Speaking at a press conference, he said that Milk, Medical, Gas distribution, Petrol Bunks, Banks will be opened as usual, he informed adding that Central Market and the Suratkal Market will remain closed.

With the Dakshin Kannada district administration relaxing the lockdown from 0600 hrs to 1500 hrs to purchase essential commodities, panic-stricken citizens rushed to the shops early in the morning itself.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.